Advertisement

Index by author

June 01, 2023; Volume 385,Issue 3

A

  1. Akers, Wendell S.

    1. In Vivo Pharmacokinetic and Pharmacodynamic Properties of the Antiarrhythmic Molecule ent-Verticilide
      Daniel J. Blackwell, Abigail N. Smith, Tri Do, Aaron Gochman, Jeffrey Schmeckpeper, Corey R. Hopkins, Wendell S. Akers, Jeffrey N. Johnston and Bjorn C. Knollmann
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 205-213; DOI: https://doi.org/10.1124/jpet.122.001455

  2. Alkhlaif, Yasmin

    1. Assessment of Abuse-Related Discriminative Stimulus Effects of Nicotine Aerosol in Rodents
      Yasmin Alkhlaif and Keith L. Shelton
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 171-179; DOI: https://doi.org/10.1124/jpet.122.001520

B

  1. Bakker, Remko A.

    1. BI-Y, an Neuropilin-1 Antagonist, Enhances Revascularization and Prevents Vascular Endothelial Growth Factor-A Induced Retinal Hyperpermeability in Rodent Models of Retinopathies
      Open Access
      BI-Y, an Neuropilin-1 Antagonist, Enhances Revascularization and Prevents Vascular Endothelial Growth Factor-A Induced Retinal Hyperpermeability in Rodent Models of Retinopathies
      Leo Thomas, Sarah Low, Gale Hansen, Remko A. Bakker and Nina Zippel
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 214-221; DOI: https://doi.org/10.1124/jpet.122.001473

  2. Baumann, Michael H.

    1. Neurochemical and Cardiovascular Effects of 4-Chloro Ring-Substituted Synthetic Cathinones in Rats
      Michael R. Chojnacki, Eric B. Thorndike, John S. Partilla, Kenner C. Rice, Charles W. Schindler and Michael H. Baumann
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 162-170; DOI: https://doi.org/10.1124/jpet.122.001478

  3. Berthold, Erin C.

    1. Pharmacokinetic and Pharmacodynamic Consequences of Cytochrome P450 3A Inhibition on Mitragynine Metabolism in Rats
      Shyam H. Kamble, Samuel Obeng, Francisco León, Luis F. Restrepo, Tamara I. King, Erin C. Berthold, Siva Rama Raju Kanumuri, Lea R. Gamez-Jimenez, Victoria L.C. Pallares, Avi Patel, Nicholas P. Ho, Aidan Hampson, Christopher R. McCurdy, Lance R. McMahon, Jenny L. Wilkerson, Abhisheak Sharma and Takato Hiranita
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 180-192; DOI: https://doi.org/10.1124/jpet.122.001525

  4. Blackwell, Daniel J.

    1. In Vivo Pharmacokinetic and Pharmacodynamic Properties of the Antiarrhythmic Molecule ent-Verticilide
      Daniel J. Blackwell, Abigail N. Smith, Tri Do, Aaron Gochman, Jeffrey Schmeckpeper, Corey R. Hopkins, Wendell S. Akers, Jeffrey N. Johnston and Bjorn C. Knollmann
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 205-213; DOI: https://doi.org/10.1124/jpet.122.001455

C

  1. Chojnacki, Michael R.

    1. Neurochemical and Cardiovascular Effects of 4-Chloro Ring-Substituted Synthetic Cathinones in Rats
      Michael R. Chojnacki, Eric B. Thorndike, John S. Partilla, Kenner C. Rice, Charles W. Schindler and Michael H. Baumann
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 162-170; DOI: https://doi.org/10.1124/jpet.122.001478

D

  1. Do, Tri

    1. In Vivo Pharmacokinetic and Pharmacodynamic Properties of the Antiarrhythmic Molecule ent-Verticilide
      Daniel J. Blackwell, Abigail N. Smith, Tri Do, Aaron Gochman, Jeffrey Schmeckpeper, Corey R. Hopkins, Wendell S. Akers, Jeffrey N. Johnston and Bjorn C. Knollmann
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 205-213; DOI: https://doi.org/10.1124/jpet.122.001455

G

  1. Gamez-Jimenez, Lea R.

    1. Pharmacokinetic and Pharmacodynamic Consequences of Cytochrome P450 3A Inhibition on Mitragynine Metabolism in Rats
      Shyam H. Kamble, Samuel Obeng, Francisco León, Luis F. Restrepo, Tamara I. King, Erin C. Berthold, Siva Rama Raju Kanumuri, Lea R. Gamez-Jimenez, Victoria L.C. Pallares, Avi Patel, Nicholas P. Ho, Aidan Hampson, Christopher R. McCurdy, Lance R. McMahon, Jenny L. Wilkerson, Abhisheak Sharma and Takato Hiranita
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 180-192; DOI: https://doi.org/10.1124/jpet.122.001525

  2. Gochman, Aaron

    1. In Vivo Pharmacokinetic and Pharmacodynamic Properties of the Antiarrhythmic Molecule ent-Verticilide
      Daniel J. Blackwell, Abigail N. Smith, Tri Do, Aaron Gochman, Jeffrey Schmeckpeper, Corey R. Hopkins, Wendell S. Akers, Jeffrey N. Johnston and Bjorn C. Knollmann
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 205-213; DOI: https://doi.org/10.1124/jpet.122.001455

H

  1. Hampson, Aidan

    1. Pharmacokinetic and Pharmacodynamic Consequences of Cytochrome P450 3A Inhibition on Mitragynine Metabolism in Rats
      Shyam H. Kamble, Samuel Obeng, Francisco León, Luis F. Restrepo, Tamara I. King, Erin C. Berthold, Siva Rama Raju Kanumuri, Lea R. Gamez-Jimenez, Victoria L.C. Pallares, Avi Patel, Nicholas P. Ho, Aidan Hampson, Christopher R. McCurdy, Lance R. McMahon, Jenny L. Wilkerson, Abhisheak Sharma and Takato Hiranita
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 180-192; DOI: https://doi.org/10.1124/jpet.122.001525

  2. Hansen, Gale

    1. BI-Y, an Neuropilin-1 Antagonist, Enhances Revascularization and Prevents Vascular Endothelial Growth Factor-A Induced Retinal Hyperpermeability in Rodent Models of Retinopathies
      Open Access
      BI-Y, an Neuropilin-1 Antagonist, Enhances Revascularization and Prevents Vascular Endothelial Growth Factor-A Induced Retinal Hyperpermeability in Rodent Models of Retinopathies
      Leo Thomas, Sarah Low, Gale Hansen, Remko A. Bakker and Nina Zippel
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 214-221; DOI: https://doi.org/10.1124/jpet.122.001473

  3. Hara, Hiroe

    1. Open Access
      TAK-994, a Novel Orally Available Brain-Penetrant Orexin 2 Receptor-Selective Agonist, Suppresses Fragmentation of Wakefulness and Cataplexy-Like Episodes in Mouse Models of Narcolepsy
      Takashi Ishikawa, Hiroe Hara, Ayumi Kawano, Kimio Tohyama, Yuichi Kajita, Yuhei Miyanohana, Tatsuki Koike and Haruhide Kimura
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 193-204; DOI: https://doi.org/10.1124/jpet.122.001449

  4. Hiranita, Takato

    1. Pharmacokinetic and Pharmacodynamic Consequences of Cytochrome P450 3A Inhibition on Mitragynine Metabolism in Rats
      Shyam H. Kamble, Samuel Obeng, Francisco León, Luis F. Restrepo, Tamara I. King, Erin C. Berthold, Siva Rama Raju Kanumuri, Lea R. Gamez-Jimenez, Victoria L.C. Pallares, Avi Patel, Nicholas P. Ho, Aidan Hampson, Christopher R. McCurdy, Lance R. McMahon, Jenny L. Wilkerson, Abhisheak Sharma and Takato Hiranita
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 180-192; DOI: https://doi.org/10.1124/jpet.122.001525

  5. Ho, Nicholas P.

    1. Pharmacokinetic and Pharmacodynamic Consequences of Cytochrome P450 3A Inhibition on Mitragynine Metabolism in Rats
      Shyam H. Kamble, Samuel Obeng, Francisco León, Luis F. Restrepo, Tamara I. King, Erin C. Berthold, Siva Rama Raju Kanumuri, Lea R. Gamez-Jimenez, Victoria L.C. Pallares, Avi Patel, Nicholas P. Ho, Aidan Hampson, Christopher R. McCurdy, Lance R. McMahon, Jenny L. Wilkerson, Abhisheak Sharma and Takato Hiranita
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 180-192; DOI: https://doi.org/10.1124/jpet.122.001525

  6. Hopkins, Corey R.

    1. In Vivo Pharmacokinetic and Pharmacodynamic Properties of the Antiarrhythmic Molecule ent-Verticilide
      Daniel J. Blackwell, Abigail N. Smith, Tri Do, Aaron Gochman, Jeffrey Schmeckpeper, Corey R. Hopkins, Wendell S. Akers, Jeffrey N. Johnston and Bjorn C. Knollmann
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 205-213; DOI: https://doi.org/10.1124/jpet.122.001455

I

  1. Ishikawa, Takashi

    1. Open Access
      TAK-994, a Novel Orally Available Brain-Penetrant Orexin 2 Receptor-Selective Agonist, Suppresses Fragmentation of Wakefulness and Cataplexy-Like Episodes in Mouse Models of Narcolepsy
      Takashi Ishikawa, Hiroe Hara, Ayumi Kawano, Kimio Tohyama, Yuichi Kajita, Yuhei Miyanohana, Tatsuki Koike and Haruhide Kimura
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 193-204; DOI: https://doi.org/10.1124/jpet.122.001449

J

  1. Johnston, Jeffrey N.

    1. In Vivo Pharmacokinetic and Pharmacodynamic Properties of the Antiarrhythmic Molecule ent-Verticilide
      Daniel J. Blackwell, Abigail N. Smith, Tri Do, Aaron Gochman, Jeffrey Schmeckpeper, Corey R. Hopkins, Wendell S. Akers, Jeffrey N. Johnston and Bjorn C. Knollmann
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 205-213; DOI: https://doi.org/10.1124/jpet.122.001455

K

  1. Kajita, Yuichi

    1. Open Access
      TAK-994, a Novel Orally Available Brain-Penetrant Orexin 2 Receptor-Selective Agonist, Suppresses Fragmentation of Wakefulness and Cataplexy-Like Episodes in Mouse Models of Narcolepsy
      Takashi Ishikawa, Hiroe Hara, Ayumi Kawano, Kimio Tohyama, Yuichi Kajita, Yuhei Miyanohana, Tatsuki Koike and Haruhide Kimura
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 193-204; DOI: https://doi.org/10.1124/jpet.122.001449

  2. Kamble, Shyam H.

    1. Pharmacokinetic and Pharmacodynamic Consequences of Cytochrome P450 3A Inhibition on Mitragynine Metabolism in Rats
      Shyam H. Kamble, Samuel Obeng, Francisco León, Luis F. Restrepo, Tamara I. King, Erin C. Berthold, Siva Rama Raju Kanumuri, Lea R. Gamez-Jimenez, Victoria L.C. Pallares, Avi Patel, Nicholas P. Ho, Aidan Hampson, Christopher R. McCurdy, Lance R. McMahon, Jenny L. Wilkerson, Abhisheak Sharma and Takato Hiranita
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 180-192; DOI: https://doi.org/10.1124/jpet.122.001525

  3. Kanumuri, Siva Rama Raju

    1. Pharmacokinetic and Pharmacodynamic Consequences of Cytochrome P450 3A Inhibition on Mitragynine Metabolism in Rats
      Shyam H. Kamble, Samuel Obeng, Francisco León, Luis F. Restrepo, Tamara I. King, Erin C. Berthold, Siva Rama Raju Kanumuri, Lea R. Gamez-Jimenez, Victoria L.C. Pallares, Avi Patel, Nicholas P. Ho, Aidan Hampson, Christopher R. McCurdy, Lance R. McMahon, Jenny L. Wilkerson, Abhisheak Sharma and Takato Hiranita
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 180-192; DOI: https://doi.org/10.1124/jpet.122.001525

  4. Kawano, Ayumi

    1. Open Access
      TAK-994, a Novel Orally Available Brain-Penetrant Orexin 2 Receptor-Selective Agonist, Suppresses Fragmentation of Wakefulness and Cataplexy-Like Episodes in Mouse Models of Narcolepsy
      Takashi Ishikawa, Hiroe Hara, Ayumi Kawano, Kimio Tohyama, Yuichi Kajita, Yuhei Miyanohana, Tatsuki Koike and Haruhide Kimura
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 193-204; DOI: https://doi.org/10.1124/jpet.122.001449

  5. Kimura, Haruhide

    1. Open Access
      TAK-994, a Novel Orally Available Brain-Penetrant Orexin 2 Receptor-Selective Agonist, Suppresses Fragmentation of Wakefulness and Cataplexy-Like Episodes in Mouse Models of Narcolepsy
      Takashi Ishikawa, Hiroe Hara, Ayumi Kawano, Kimio Tohyama, Yuichi Kajita, Yuhei Miyanohana, Tatsuki Koike and Haruhide Kimura
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 193-204; DOI: https://doi.org/10.1124/jpet.122.001449

  6. King, Tamara I.

    1. Pharmacokinetic and Pharmacodynamic Consequences of Cytochrome P450 3A Inhibition on Mitragynine Metabolism in Rats
      Shyam H. Kamble, Samuel Obeng, Francisco León, Luis F. Restrepo, Tamara I. King, Erin C. Berthold, Siva Rama Raju Kanumuri, Lea R. Gamez-Jimenez, Victoria L.C. Pallares, Avi Patel, Nicholas P. Ho, Aidan Hampson, Christopher R. McCurdy, Lance R. McMahon, Jenny L. Wilkerson, Abhisheak Sharma and Takato Hiranita
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 180-192; DOI: https://doi.org/10.1124/jpet.122.001525

  7. Knollmann, Bjorn C.

    1. In Vivo Pharmacokinetic and Pharmacodynamic Properties of the Antiarrhythmic Molecule ent-Verticilide
      Daniel J. Blackwell, Abigail N. Smith, Tri Do, Aaron Gochman, Jeffrey Schmeckpeper, Corey R. Hopkins, Wendell S. Akers, Jeffrey N. Johnston and Bjorn C. Knollmann
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 205-213; DOI: https://doi.org/10.1124/jpet.122.001455

  8. Koike, Tatsuki

    1. Open Access
      TAK-994, a Novel Orally Available Brain-Penetrant Orexin 2 Receptor-Selective Agonist, Suppresses Fragmentation of Wakefulness and Cataplexy-Like Episodes in Mouse Models of Narcolepsy
      Takashi Ishikawa, Hiroe Hara, Ayumi Kawano, Kimio Tohyama, Yuichi Kajita, Yuhei Miyanohana, Tatsuki Koike and Haruhide Kimura
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 193-204; DOI: https://doi.org/10.1124/jpet.122.001449

L

  1. León, Francisco

    1. Pharmacokinetic and Pharmacodynamic Consequences of Cytochrome P450 3A Inhibition on Mitragynine Metabolism in Rats
      Shyam H. Kamble, Samuel Obeng, Francisco León, Luis F. Restrepo, Tamara I. King, Erin C. Berthold, Siva Rama Raju Kanumuri, Lea R. Gamez-Jimenez, Victoria L.C. Pallares, Avi Patel, Nicholas P. Ho, Aidan Hampson, Christopher R. McCurdy, Lance R. McMahon, Jenny L. Wilkerson, Abhisheak Sharma and Takato Hiranita
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 180-192; DOI: https://doi.org/10.1124/jpet.122.001525

  2. Low, Sarah

    1. BI-Y, an Neuropilin-1 Antagonist, Enhances Revascularization and Prevents Vascular Endothelial Growth Factor-A Induced Retinal Hyperpermeability in Rodent Models of Retinopathies
      Open Access
      BI-Y, an Neuropilin-1 Antagonist, Enhances Revascularization and Prevents Vascular Endothelial Growth Factor-A Induced Retinal Hyperpermeability in Rodent Models of Retinopathies
      Leo Thomas, Sarah Low, Gale Hansen, Remko A. Bakker and Nina Zippel
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 214-221; DOI: https://doi.org/10.1124/jpet.122.001473

M

  1. McCurdy, Christopher R.

    1. Pharmacokinetic and Pharmacodynamic Consequences of Cytochrome P450 3A Inhibition on Mitragynine Metabolism in Rats
      Shyam H. Kamble, Samuel Obeng, Francisco León, Luis F. Restrepo, Tamara I. King, Erin C. Berthold, Siva Rama Raju Kanumuri, Lea R. Gamez-Jimenez, Victoria L.C. Pallares, Avi Patel, Nicholas P. Ho, Aidan Hampson, Christopher R. McCurdy, Lance R. McMahon, Jenny L. Wilkerson, Abhisheak Sharma and Takato Hiranita
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 180-192; DOI: https://doi.org/10.1124/jpet.122.001525

  2. McMahon, Lance R.

    1. Pharmacokinetic and Pharmacodynamic Consequences of Cytochrome P450 3A Inhibition on Mitragynine Metabolism in Rats
      Shyam H. Kamble, Samuel Obeng, Francisco León, Luis F. Restrepo, Tamara I. King, Erin C. Berthold, Siva Rama Raju Kanumuri, Lea R. Gamez-Jimenez, Victoria L.C. Pallares, Avi Patel, Nicholas P. Ho, Aidan Hampson, Christopher R. McCurdy, Lance R. McMahon, Jenny L. Wilkerson, Abhisheak Sharma and Takato Hiranita
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 180-192; DOI: https://doi.org/10.1124/jpet.122.001525

  3. Miyanohana, Yuhei

    1. Open Access
      TAK-994, a Novel Orally Available Brain-Penetrant Orexin 2 Receptor-Selective Agonist, Suppresses Fragmentation of Wakefulness and Cataplexy-Like Episodes in Mouse Models of Narcolepsy
      Takashi Ishikawa, Hiroe Hara, Ayumi Kawano, Kimio Tohyama, Yuichi Kajita, Yuhei Miyanohana, Tatsuki Koike and Haruhide Kimura
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 193-204; DOI: https://doi.org/10.1124/jpet.122.001449

O

  1. Obeng, Samuel

    1. Pharmacokinetic and Pharmacodynamic Consequences of Cytochrome P450 3A Inhibition on Mitragynine Metabolism in Rats
      Shyam H. Kamble, Samuel Obeng, Francisco León, Luis F. Restrepo, Tamara I. King, Erin C. Berthold, Siva Rama Raju Kanumuri, Lea R. Gamez-Jimenez, Victoria L.C. Pallares, Avi Patel, Nicholas P. Ho, Aidan Hampson, Christopher R. McCurdy, Lance R. McMahon, Jenny L. Wilkerson, Abhisheak Sharma and Takato Hiranita
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 180-192; DOI: https://doi.org/10.1124/jpet.122.001525

P

  1. Pallares, Victoria L.C.

    1. Pharmacokinetic and Pharmacodynamic Consequences of Cytochrome P450 3A Inhibition on Mitragynine Metabolism in Rats
      Shyam H. Kamble, Samuel Obeng, Francisco León, Luis F. Restrepo, Tamara I. King, Erin C. Berthold, Siva Rama Raju Kanumuri, Lea R. Gamez-Jimenez, Victoria L.C. Pallares, Avi Patel, Nicholas P. Ho, Aidan Hampson, Christopher R. McCurdy, Lance R. McMahon, Jenny L. Wilkerson, Abhisheak Sharma and Takato Hiranita
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 180-192; DOI: https://doi.org/10.1124/jpet.122.001525

  2. Partilla, John S.

    1. Neurochemical and Cardiovascular Effects of 4-Chloro Ring-Substituted Synthetic Cathinones in Rats
      Michael R. Chojnacki, Eric B. Thorndike, John S. Partilla, Kenner C. Rice, Charles W. Schindler and Michael H. Baumann
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 162-170; DOI: https://doi.org/10.1124/jpet.122.001478

  3. Patel, Avi

    1. Pharmacokinetic and Pharmacodynamic Consequences of Cytochrome P450 3A Inhibition on Mitragynine Metabolism in Rats
      Shyam H. Kamble, Samuel Obeng, Francisco León, Luis F. Restrepo, Tamara I. King, Erin C. Berthold, Siva Rama Raju Kanumuri, Lea R. Gamez-Jimenez, Victoria L.C. Pallares, Avi Patel, Nicholas P. Ho, Aidan Hampson, Christopher R. McCurdy, Lance R. McMahon, Jenny L. Wilkerson, Abhisheak Sharma and Takato Hiranita
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 180-192; DOI: https://doi.org/10.1124/jpet.122.001525

R

  1. Rawls, Scott M.

    1. Bath Salts to Therapies: Can Separation of Adverse and Therapeutic Effects of Substituted Cathinones Lead to a Medication for Psychostimulant Use Disorder?
      Ellen M. Unterwald and Scott M. Rawls
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 159-161; DOI: https://doi.org/10.1124/jpet.123.001650

  2. Restrepo, Luis F.

    1. Pharmacokinetic and Pharmacodynamic Consequences of Cytochrome P450 3A Inhibition on Mitragynine Metabolism in Rats
      Shyam H. Kamble, Samuel Obeng, Francisco León, Luis F. Restrepo, Tamara I. King, Erin C. Berthold, Siva Rama Raju Kanumuri, Lea R. Gamez-Jimenez, Victoria L.C. Pallares, Avi Patel, Nicholas P. Ho, Aidan Hampson, Christopher R. McCurdy, Lance R. McMahon, Jenny L. Wilkerson, Abhisheak Sharma and Takato Hiranita
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 180-192; DOI: https://doi.org/10.1124/jpet.122.001525

  3. Rice, Kenner C.

    1. Neurochemical and Cardiovascular Effects of 4-Chloro Ring-Substituted Synthetic Cathinones in Rats
      Michael R. Chojnacki, Eric B. Thorndike, John S. Partilla, Kenner C. Rice, Charles W. Schindler and Michael H. Baumann
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 162-170; DOI: https://doi.org/10.1124/jpet.122.001478

S

  1. Schindler, Charles W.

    1. Neurochemical and Cardiovascular Effects of 4-Chloro Ring-Substituted Synthetic Cathinones in Rats
      Michael R. Chojnacki, Eric B. Thorndike, John S. Partilla, Kenner C. Rice, Charles W. Schindler and Michael H. Baumann
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 162-170; DOI: https://doi.org/10.1124/jpet.122.001478

  2. Schmeckpeper, Jeffrey

    1. In Vivo Pharmacokinetic and Pharmacodynamic Properties of the Antiarrhythmic Molecule ent-Verticilide
      Daniel J. Blackwell, Abigail N. Smith, Tri Do, Aaron Gochman, Jeffrey Schmeckpeper, Corey R. Hopkins, Wendell S. Akers, Jeffrey N. Johnston and Bjorn C. Knollmann
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 205-213; DOI: https://doi.org/10.1124/jpet.122.001455

  3. Sharma, Abhisheak

    1. Pharmacokinetic and Pharmacodynamic Consequences of Cytochrome P450 3A Inhibition on Mitragynine Metabolism in Rats
      Shyam H. Kamble, Samuel Obeng, Francisco León, Luis F. Restrepo, Tamara I. King, Erin C. Berthold, Siva Rama Raju Kanumuri, Lea R. Gamez-Jimenez, Victoria L.C. Pallares, Avi Patel, Nicholas P. Ho, Aidan Hampson, Christopher R. McCurdy, Lance R. McMahon, Jenny L. Wilkerson, Abhisheak Sharma and Takato Hiranita
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 180-192; DOI: https://doi.org/10.1124/jpet.122.001525

  4. Shelton, Keith L.

    1. Assessment of Abuse-Related Discriminative Stimulus Effects of Nicotine Aerosol in Rodents
      Yasmin Alkhlaif and Keith L. Shelton
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 171-179; DOI: https://doi.org/10.1124/jpet.122.001520

  5. Smith, Abigail N.

    1. In Vivo Pharmacokinetic and Pharmacodynamic Properties of the Antiarrhythmic Molecule ent-Verticilide
      Daniel J. Blackwell, Abigail N. Smith, Tri Do, Aaron Gochman, Jeffrey Schmeckpeper, Corey R. Hopkins, Wendell S. Akers, Jeffrey N. Johnston and Bjorn C. Knollmann
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 205-213; DOI: https://doi.org/10.1124/jpet.122.001455

T

  1. Thomas, Leo

    1. BI-Y, an Neuropilin-1 Antagonist, Enhances Revascularization and Prevents Vascular Endothelial Growth Factor-A Induced Retinal Hyperpermeability in Rodent Models of Retinopathies
      Open Access
      BI-Y, an Neuropilin-1 Antagonist, Enhances Revascularization and Prevents Vascular Endothelial Growth Factor-A Induced Retinal Hyperpermeability in Rodent Models of Retinopathies
      Leo Thomas, Sarah Low, Gale Hansen, Remko A. Bakker and Nina Zippel
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 214-221; DOI: https://doi.org/10.1124/jpet.122.001473

  2. Thorndike, Eric B.

    1. Neurochemical and Cardiovascular Effects of 4-Chloro Ring-Substituted Synthetic Cathinones in Rats
      Michael R. Chojnacki, Eric B. Thorndike, John S. Partilla, Kenner C. Rice, Charles W. Schindler and Michael H. Baumann
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 162-170; DOI: https://doi.org/10.1124/jpet.122.001478

  3. Tohyama, Kimio

    1. Open Access
      TAK-994, a Novel Orally Available Brain-Penetrant Orexin 2 Receptor-Selective Agonist, Suppresses Fragmentation of Wakefulness and Cataplexy-Like Episodes in Mouse Models of Narcolepsy
      Takashi Ishikawa, Hiroe Hara, Ayumi Kawano, Kimio Tohyama, Yuichi Kajita, Yuhei Miyanohana, Tatsuki Koike and Haruhide Kimura
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 193-204; DOI: https://doi.org/10.1124/jpet.122.001449

U

  1. Unterwald, Ellen M.

    1. Bath Salts to Therapies: Can Separation of Adverse and Therapeutic Effects of Substituted Cathinones Lead to a Medication for Psychostimulant Use Disorder?
      Ellen M. Unterwald and Scott M. Rawls
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 159-161; DOI: https://doi.org/10.1124/jpet.123.001650

W

  1. Wilkerson, Jenny L.

    1. Pharmacokinetic and Pharmacodynamic Consequences of Cytochrome P450 3A Inhibition on Mitragynine Metabolism in Rats
      Shyam H. Kamble, Samuel Obeng, Francisco León, Luis F. Restrepo, Tamara I. King, Erin C. Berthold, Siva Rama Raju Kanumuri, Lea R. Gamez-Jimenez, Victoria L.C. Pallares, Avi Patel, Nicholas P. Ho, Aidan Hampson, Christopher R. McCurdy, Lance R. McMahon, Jenny L. Wilkerson, Abhisheak Sharma and Takato Hiranita
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 180-192; DOI: https://doi.org/10.1124/jpet.122.001525

Z

  1. Zippel, Nina

    1. BI-Y, an Neuropilin-1 Antagonist, Enhances Revascularization and Prevents Vascular Endothelial Growth Factor-A Induced Retinal Hyperpermeability in Rodent Models of Retinopathies
      Open Access
      BI-Y, an Neuropilin-1 Antagonist, Enhances Revascularization and Prevents Vascular Endothelial Growth Factor-A Induced Retinal Hyperpermeability in Rodent Models of Retinopathies
      Leo Thomas, Sarah Low, Gale Hansen, Remko A. Bakker and Nina Zippel
      Journal of Pharmacology and Experimental Therapeutics June 2023, 385 (3) 214-221; DOI: https://doi.org/10.1124/jpet.122.001473
Back to top

In this issue

Advertisement